Solexa, Inc.
25861 Industrial Boulevard
Hayward
California
94545
United States
Tel: 510-670-9300
Fax: 510-670-9302
Website: http://www.solexa.com/
Email: info@solexa.com
About Solexa, Inc.
Solexa is developing DNA sequencing systems for the comprehensive and economical analysis of whole genomes. These systems are intended for use by customers in a wide range of applications from basic research through to the development and implementation of personalized medicine. The amount of information required about individual genomes depends upon the scientific application. Present methods generally provide insufficient information and are costly, which has inhibited progress, for instance in understanding the genetic components of common human diseases and the variable response of individuals to drugs. The systems Solexa is developing are designed to provide very large amounts of information about individual genomes including the entire individual human genomic sequence, and to do so economically.Solexa was formed by the recent combination of Solexa Limited with Lynx Therapeutics, Inc. Solexa will continue to provide ultra-high volume DNA sequencing services from its Hayward production facility via the Lynx bead-based technology platform until the new fully automated Cluster-SBS instruments begin replacing the older systems later this year and into early 2006. The bead-based systems are mainly used for genome-wide, comprehensive gene expression and small RNA analysis, and the Cluster-SBS technology will enable sequencing services for the broad genome analysis community. Solexa expects to begin placing Cluster-SBS instruments in its production facility and development partner laboratories by the end of this year and to begin broad commercial sale of instruments in early 2006.
Key Contacts:
John West CEO
Mary L. Schramke Vice President & General Manager, Genomic Services
Kathy A. San Roman Vice President, Human Resources & Administration
Thomas J. Vasicek, Ph.D. Vice President, Business Development
Last Updated: 03-11-05
33 articles about Solexa, Inc.
-
Solexa, Inc. Genome Analysis System Achieves 1G Performance Milestone
1/8/2007
-
Applera Corporation Initiates Suit Against Solexa, Inc. Seeking Ownership Of Patents Covering Sequencing-By-Ligation Technologies
1/2/2007
-
Illumina, Inc. Obtains HSR Clearance To Acquire Solexa, Inc.
12/21/2006
-
Solexa, Inc. Announces Third Quarter 2006 Financial Results
11/13/2006
-
Solexa, Inc. Announces Third Quarter 2006 Financial Results Conference Call On November 14
11/8/2006
-
Solexa, Inc. Announces Sequencing Of A Human X-Chromosome
10/18/2006
-
Solexa, Inc. Announces Results Of Annual Meeting Of Stockholders
10/5/2006
-
Solexa, Inc. Appoints Blaine Bowman And Roy Whitfield To Board Of Directors
8/31/2006
-
Solexa, Inc. To Present At The Thomas Weisel Partners Healthcare Conference 2006
8/29/2006
-
Solexa, Inc. Announces Second Quarter 2006 Financial Results; Provides Update On Early Access Program For Solexa, Inc. Genome Analysis System
8/15/2006
-
Solexa, Inc. Appoints Frank Oaks Vice President, DNA Sequencing Services
8/14/2006
-
Solexa, Inc. To Hold Second Quarter 2006 Financial Results Conference Call On August 14
8/2/2006
-
Solexa, Inc. Appoints Joseph Whitters To Board Of Directors
8/2/2006
-
Solexa, Inc. And New England Biolabs, Inc. Announce Enzyme Supply Agreement; New England Biolabs, Inc. To Manufacture Key Polymerase For The Solexa Genome Analysis System
8/1/2006
-
Solexa, Inc. Names Richard H. Lussier Vice President, Sales And Field Operations
7/5/2006
-
Invitrogen Corporation And Solexa, Inc. Collaborate To Supply Reagents For Next Generation Sequencing Technology
6/13/2006
-
Solexa, Inc. To Present At Pacific Growth Equities 2006 Life Sciences Growth Conference
6/6/2006
-
Solexa, Inc. Files $100 Million Shelf Registration
5/19/2006
-
Solexa, Inc. Added To NASDAQ Biotech Index
5/16/2006
-
Solexa, Inc. 1Q Loss Widens As Expenses Jump
5/16/2006